These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 3121519

  • 1. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis.
    Bauernfeind A, Emminger G, Hörl G, Ott S, Przyklenk B, Weisslein-Pfister C.
    Infection; 1987; 15(5):403-6. PubMed ID: 3121519
    [Abstract] [Full Text] [Related]

  • 2. Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa.
    Weiss K, Lapointe JR.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2411-4. PubMed ID: 8585718
    [Abstract] [Full Text] [Related]

  • 3. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2012 Nov 14; 11():CD009528. PubMed ID: 23152277
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.
    Smith DJ, Ramsay KA, Yerkovich ST, Reid DW, Wainwright CE, Grimwood K, Bell SC, Kidd TJ.
    Respirology; 2016 Feb 14; 21(2):329-37. PubMed ID: 26711802
    [Abstract] [Full Text] [Related]

  • 9. Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients.
    Finklea JD, Hollaway R, Lowe K, Lee F, Le J, Jain R.
    Diagn Microbiol Infect Dis; 2018 Sep 14; 92(1):75-77. PubMed ID: 29884565
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW, Robson CL, Watts AM, Gray AR, Wainwright CE, Bell SC, Ramsay KA, Kidd TJ, Reid DW, Brockway B, Lamont IL.
    Antimicrob Agents Chemother; 2018 Nov 14; 62(11):. PubMed ID: 30201819
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.
    Gaillard JL, Cahen P, Delacourt C, Silly C, Le Bourgeois M, Coustère C, de Blic J, Lenoir G, Scheinmann P.
    Eur J Clin Microbiol Infect Dis; 1995 Apr 14; 14(4):291-6. PubMed ID: 7649191
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
    Zabner R, Quinn JP.
    Semin Respir Infect; 1992 Sep 14; 7(3):210-7. PubMed ID: 1475544
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.